Clinical Trial Update: Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Regenexx®SD treatment for osteoarthritis of the knee and its relation to clinical outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• Regenexx SD

Snippet

Sponsor: Regenexx, LLC | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED